中文
About Us
Corporate Overview
Management Team
Board of Directors
Our Science
Anti-viral Platform
RNA Interference
Fatty Liver Disease
Products & Pipline
Overview
HCV
HBV
ASC09
ASC06
Partnership
Investors
Financials & Filing
Presentation Materials
News
2020
2019
2018
2017
2016
2015
2014
Careers
2020
2019
2018
2017
2016
2015
2014
Data on NASH Candidate ASC40 to be Presented at EASL ILC 2020
2020-04-01
Results from First Clinical Study Using Danoprevir to Treat Naive and Experienced COVID-19 Patients
2020-03-25
Progress of the Small Sample Clinical Trial of Ganovo® and Ritonavir Combination Therapy on Novel Coronavirus Pneumonia
2020-03-10
Clinical Trial of Ganovo® and Ritonavir Combination Therapy on Novel Coronavirus Pneumonia
2020-02-27
Ascletis’ IND Filing for Its Non-alcoholic Steatohepatitis (NASH) Drug Accepted by NMPA
2020-02-18
«
1
2
3
»
